$3.09
-0.01[-0.32%]
At close: May 20
$3.09
0[0.00%]
After Hours: 5:08PM EDT
Arcadia Biosciences
(NASDAQ:RKDA)Arcadia Biosciences Stock (NASDAQ:RKDA), Analyst Ratings, Price Targets, Predictions
Arcadia Biosciences Inc has a consensus price target of $10, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 5, 2024, August 28, 2023, and July 24, 2023. With an average price target of $11.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 277.56% upside for Arcadia Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Arcadia Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/05/2024 | Buy Now | 223.62% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | Buy Now | 223.62% | HC Wainwright & Co. | Raghuram Selvaraju | $15 → $10 | Maintains | Buy | Get Alert |
| 07/24/2023 | Buy Now | 385.44% | HC Wainwright & Co. | Raghuram Selvaraju | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 385.44% | HC Wainwright & Co. | Raghuram Selvaraju | $18 → $15 | Maintains | Buy | Get Alert |
| 04/14/2023 | Buy Now | 482.52% | HC Wainwright & Co. | Raghuram Selvaraju | $3 → $18 | Maintains | Buy | Get Alert |
| 08/26/2022 | Buy Now | -2.91% | HC Wainwright & Co. | Raghuram Selvaraju | $160 → $120 | Maintains | Buy | Get Alert |
| 01/03/2022 | Buy Now | 94.17% | HC Wainwright & Co. | Raghuram Selvaraju | $280 → $240 | Maintains | Buy | Get Alert |
| 06/01/2021 | Buy Now | 126.54% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Arcadia Biosciences (RKDA)?
The latest price target for Arcadia Biosciences (NASDAQ: RKDA) was reported by HC Wainwright & Co. on April 5, 2024. The analyst firm set a price target for $10.00 expecting RKDA to rise to within 12 months (a possible 223.62% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Arcadia Biosciences (RKDA)?
The latest analyst rating for Arcadia Biosciences (NASDAQ: RKDA) was provided by HC Wainwright & Co., and Arcadia Biosciences reiterated their buy rating.
When was the last upgrade for Arcadia Biosciences (RKDA)?
There is no last upgrade for Arcadia Biosciences.
When was the last downgrade for Arcadia Biosciences (RKDA)?
There is no last downgrade for Arcadia Biosciences.
When is the next analyst rating going to be posted or updated for Arcadia Biosciences (RKDA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcadia Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcadia Biosciences was filed on April 5, 2024 so you should expect the next rating to be made available sometime around April 5, 2025.
Is the Analyst Rating Arcadia Biosciences (RKDA) correct?
While ratings are subjective and will change, the latest Arcadia Biosciences (RKDA) rating was a reiterated with a price target of $0.00 to $10.00. The current price Arcadia Biosciences (RKDA) is trading at is $3.09, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.